Bid Publish Date
08-Jan-2026, 6:17 pm
Bid End Date
19-Jan-2026, 7:00 pm
Location
Progress
RAQuantity
136560
Category
SITAGLIPTIN 50MG, METFORMIN 1000MG TAB
Bid Type
Two Packet Bid
The Indian Navy, Department of Military Affairs, invites bids for pharmaceutical products (diabetes tablets) in Uttara Kannada, Karnataka 581121. The procurement covers a broad range of glycemic agents (ACARBOSE, DAPAGLIFLOZIN, GLIBENCLAMIDE, GLIPIZIDE, METFORMIN, SITAGLIPTIN, VILDAGLIPTIN, VOGLIBOSE, LINAGLIPTIN, GLIMEPIRIDE) across 19 items. Although exact quantities and total estimated value are not disclosed, the scope is supplier-driven with quantity flex as per contract terms. The tender emphasizes compliant manufacturers and holistic supplier readiness for government procurement processes in the Karnataka region. A key differentiator is the option clause enabling up to 50% quantity adjustments during and after contract award, with delivery timelines anchored to the original delivery period and extended calculations. This tender signals a centralized government medical procurement channel for validated generics and branded equivalents under strict regulatory norms.
Product/service: Diabetes tablets including ACARBOSE, DAPAGLIFLOZIN, GLIBENCLAMIDE, GLIMEPIRIDE, METFORMIN, SITAGLIPTIN, LINAGLIPTIN, VILDAGLIPTIN, VOGLIBOSE, GLIPIZIDE
Quantities: 19 items; exact quantities not disclosed
Est. value: Not disclosed
Experience: Not specified in data; expect standard pharmaceutical supply capabilities
Quality/standards: GMP/Pharma regulatory compliance anticipated
Up to 50% quantity variation during contract at contracted rates
Delivery time calculated per formula with a minimum 30 days
Submit PAN, GSTIN, cancelled cheque, and EFT mandate
Authority to adjust quantities by +/-50% at award and during currency; delivery timelines adjust accordingly
Delivery period commences from last date of original delivery order; extended period follows the option clause calculation
Not explicitly specified; bidders should anticipate standard government payment processes
Registered pharmaceutical supplier with GSTIN
Ability to supply a wide range of diabetes tablets across listed formulations
Compliance with government procurement terms and ability to provide EFT-based payment documentation
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
ACARBOSE 25MG TAB , ACARBOSE 50MG TAB , DAPAGLIFLOZIN 10MG TAB , DAPAGLIFLOZIN 5MG TAB , GLIBENCLAMIDE 5MG TAB , GLICLAZIDE 40MG TAB , GLICLAZIDE 60MG TAB , GLIMEPIRIDE 1MG, METFORMIN 500MG TAB , GLIMEPIRIDE 2MG, METFORMIN 1000MG TAB , GLIMEPIRIDE 2MG TAB , GLIPIZIDE 5MG TAB , LINAGLIPTIN 2.5MG TAB , METFORMIN 250MG TAB , SITAGLIPTIN 100MG TAB , SITAGLIPTIN 50MG TAB , SITAGLIPTIN 50MG, METFORMIN 1000MG TAB , SITAGLIPTIN 50MG, METFORMIN 500MG TAB , VILDAGLIPTIN 50MG TAB , VOGLIBOSE 0.3MG TAB
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
ACARBOSE 25MG TAB
ACARBOSE 25MG TAB
ACARBOSE 50MG TAB
ACARBOSE 50MG TAB
DAPAGLIFLOZIN 10MG TAB
DAPAGLIFLOZIN 10MG TAB
DAPAGLIFLOZIN 5MG TAB
DAPAGLIFLOZIN 5MG TAB
GLIBENCLAMIDE 5MG TAB
GLIBENCLAMIDE 5MG TAB
GLICLAZIDE 40MG TAB
GLICLAZIDE 40MG TAB
GLICLAZIDE 60MG TAB
GLICLAZIDE 60MG TAB
GLIMEPIRIDE 1MG, METFORMIN 500MG TAB
GLIMEPIRIDE 1MG, METFORMIN 500MG TAB
GLIMEPIRIDE 2MG, METFORMIN 1000MG TAB
GLIMEPIRIDE 2MG, METFORMIN 1000MG TAB
GLIMEPIRIDE 2MG TAB
GLIMEPIRIDE 2MG TAB
GLIPIZIDE 5MG TAB
GLIPIZIDE 5MG TAB
LINAGLIPTIN 2.5MG TAB
LINAGLIPTIN 2.5MG TAB
METFORMIN 250MG TAB
METFORMIN 250MG TAB
SITAGLIPTIN 100MG TAB
SITAGLIPTIN 100MG TAB
SITAGLIPTIN 50MG TAB
SITAGLIPTIN 50MG TAB
SITAGLIPTIN 50MG, METFORMIN 1000MG TAB
SITAGLIPTIN 50MG, METFORMIN 1000MG TAB
SITAGLIPTIN 50MG, METFORMIN 500MG TAB
SITAGLIPTIN 50MG, METFORMIN 500MG TAB
VILDAGLIPTIN 50MG TAB
VILDAGLIPTIN 50MG TAB
VOGLIBOSE 0.3MG TAB
VOGLIBOSE 0.3MG TAB
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | ACARBOSE 25MG TAB | ACARBOSE 25MG TAB | 400 | pieces | oicmsptj | 30 | |
| 2 | ACARBOSE 50MG TAB | ACARBOSE 50MG TAB | 1,000 | pieces | oicmsptj | 30 | |
| 3 | DAPAGLIFLOZIN 10MG TAB | DAPAGLIFLOZIN 10MG TAB | 2,600 | pieces | oicmsptj | 30 | |
| 4 | DAPAGLIFLOZIN 5MG TAB | DAPAGLIFLOZIN 5MG TAB | 2,000 | pieces | oicmsptj | 30 | |
| 5 | GLIBENCLAMIDE 5MG TAB | GLIBENCLAMIDE 5MG TAB | 360 | pieces | oicmsptj | 30 | |
| 6 | GLICLAZIDE 40MG TAB | GLICLAZIDE 40MG TAB | 1,300 | pieces | oicmsptj | 30 | |
| 7 | GLICLAZIDE 60MG TAB | GLICLAZIDE 60MG TAB | 3,000 | pieces | oicmsptj | 30 | |
| 8 | GLIMEPIRIDE 1MG, METFORMIN 500MG TAB | GLIMEPIRIDE 1MG, METFORMIN 500MG TAB | 1,000 | pieces | oicmsptj | 30 | |
| 9 | GLIMEPIRIDE 2MG, METFORMIN 1000MG TAB | GLIMEPIRIDE 2MG, METFORMIN 1000MG TAB | 3,000 | pieces | oicmsptj | 30 | |
| 10 | GLIMEPIRIDE 2MG TAB | GLIMEPIRIDE 2MG TAB | 18,000 | pieces | oicmsptj | 30 | |
| 11 | GLIPIZIDE 5MG TAB | GLIPIZIDE 5MG TAB | 600 | pieces | oicmsptj | 30 | |
| 12 | LINAGLIPTIN 2.5MG TAB | LINAGLIPTIN 2.5MG TAB | 500 | pieces | oicmsptj | 30 | |
| 13 | METFORMIN 250MG TAB | METFORMIN 250MG TAB | 800 | pieces | oicmsptj | 30 | |
| 14 | SITAGLIPTIN 100MG TAB | SITAGLIPTIN 100MG TAB | 3,000 | pieces | oicmsptj | 30 | |
| 15 | SITAGLIPTIN 50MG TAB | SITAGLIPTIN 50MG TAB | 30,000 | pieces | oicmsptj | 30 | |
| 16 | SITAGLIPTIN 50MG, METFORMIN 1000MG TAB | SITAGLIPTIN 50MG, METFORMIN 1000MG TAB | 36,000 | pieces | oicmsptj | 30 | |
| 17 | SITAGLIPTIN 50MG, METFORMIN 500MG TAB | SITAGLIPTIN 50MG, METFORMIN 500MG TAB | 2,000 | pieces | oicmsptj | 30 | |
| 18 | VILDAGLIPTIN 50MG TAB | VILDAGLIPTIN 50MG TAB | 21,000 | pieces | oicmsptj | 30 | |
| 19 | VOGLIBOSE 0.3MG TAB | VOGLIBOSE 0.3MG TAB | 10,000 | pieces | oicmsptj | 30 |
PAN Card copy
GSTIN copy
Cancelled Cheque copy
EFT Mandate copy certified by bank
Any additional vendor registration or authorization documents
Start
22-Jan-2026, 5:00 pm
End
27-Jan-2026, 11:00 am
Duration: 114 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 17-01-2026 22:56:57 | |
| 2 | ********** Under PMA | - | 19-01-2026 07:03:34 | |
| 3 | ********** Under PMA | - | 18-01-2026 21:23:35 | |
| 4 | ********** Under PMA | - | 14-01-2026 16:00:53 | |
| 5 | ********** Under PMA | - | 16-01-2026 15:24:11 | |
| 6 | ********** Under PMA | - | 18-01-2026 17:42:41 | |
| 7 | ********** Under PMA | - | 09-01-2026 17:53:05 | |
| 8 | ********** Under PMA | - | 19-01-2026 18:53:37 | |
| 9 | ********** Under PMA | - | 17-01-2026 16:52:19 | |
| 10 | ********** Under PMA | - | 16-01-2026 00:59:57 | |
| 11 | ********** Under PMA | - | 19-01-2026 18:16:23 | |
| 12 | ********** Under PMA | - | 17-01-2026 12:49:41 |
Key insights about KARNATAKA tender market
Bidders should register as a vendor, obtain GSTIN and PAN, and prepare an EFT Mandate with bank certification. The tender permits up to 50% quantity variation and requires compliance with government procurement rules. Ensure you can supply listed formulations and provide all required documents with bid submission.
Submit PAN, GSTIN, Cancelled Cheque, and EFT Mandate certified by bank. Additional vendor registration documents may be needed. Ensure all copies are clear and current, reflect organization details, and match bidder's bank account used for payments.
Delivery is governed by the option clause: increased/decreased quantities up to 50% at contract award, with delivery period calculated by (Increased quantity ÷ Original quantity) × Original delivery period, minimum 30 days. Original delivery timelines apply unless extensions are invoked.
The catalogue includes ACARBOSE 25MG/50MG, DAPAGLIFLOZIN 5MG/10MG, GLIBENCLAMIDE 5MG, GLICLAZIDE variants, GLIMEPIRIDE 1MG/2MG, METFORMIN 250/500/1000MG, GLIPIZIDE 5MG, SITAGLIPTIN 50/100MG, LINAGLIPTIN 2.5MG, VILDAGLIPTIN 50MG, VOGLIBOSE 0.3MG, across 19 items with unspecified quantities.
Eligible bidders must be GST registered, possess PAN, provide a bank EFT mandate, and have capability to supply a range of diabetes tablets. While explicit experience years aren’t stated, bidders should demonstrate pharmaceutical supply experience and compliance with government procurement norms.
Exact submission deadline is not provided in the data. Bidders should monitor official procurement notices and ensure readiness with all mandatory documents (PAN, GST, EFT mandate) and product compliance certificates to avoid last-minute delays.
Although explicit standards aren’t listed, suppliers should prepare GMP/compliance documentation typical for pharmaceutical government procurements, ensuring product quality and regulatory adherence for diabetes tablets, with transparent batch, expiry, and manufacturing details.
Anticipate potential order fluctuations up to ±50%. Plan production and inventory to accommodate sudden quantity changes, calculate delivery extensions using the specified formula, and align with contractor timelines to avoid penalties or non-compliance.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS